Characterising the castration‐resistant prostate cancer population: a systematic review
By M. Kirby, C. Hirst, E. Crawford. International journal of clinical practice, 2011
805 citations recorded by the source corpus.
Background: Castration‐resistant prostate cancer (CRPC) is an advanced form of prostate cancer associated with poor survival rates. However, characterisation of the disease epidemiology is hampered by use of varying terminology, definition and disease management. The aim of this review was to conduct a systematic review to provide greater clarity on the sum of the available epidemiologic evidence and to guide future research into the disease prevalence, progression, characteristics and outcome.
Subfields: Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/34a38b4769689a47168a999bb7e93b65659bfe87
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Prostate Cancer (2018, methodology): “African-American men without prostate cancer also have significantly higher PSA density when compared to Caucasian men [23].”